Sr. Director, Quantitative Systems Pharmacology
Incyte Corporation
Dr. Limei Cheng is a seasoned expert in quantitative systems pharmacology and pharmacomentrics with over 20 years of experience in algorithm development, modeling, and simulation for healthcare applications and pharmaceutical drug development. She currently serves as the Senior Director and QSP Lead of Clinical and Quantitative Pharmacologyat Incyte Corporation, where she applies model-based QSP methods of Model-Informed Drug Development to integrate clinical and preclinical data, providing valuable predictive insights for decision-making. Before joining Incyte, Dr. Cheng led the QSP-CV group at Bristol Myers Squibb, contributing nearly eight years of her expertise. Dr. Cheng’s work has produced numerous publications and presentations that highlight the significance of systems pharmacology in pharmaceutical R&D. Her primary interests include QSP modeling, virtual population simulation, and applications of machine learning and AI in precision medicine.